The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
A large international trial has overwhelmingly concluded that the health of people living with HIV considerably benefits from starting treatment early. It is widely acknowledged that giving antiretrovirals (ARVs) to HIV positive people before their CD4 count – a measure of the immune system – drops too low, makes treatment more effective. This study provides crucial new evidence that could be a game-changer in the delivery of HIV treatment around the world.
A leading Russian epidemiologist, Vadim Pokrovsky, has raised the alarm on the rising numbers of people becoming infected with HIV in Russia. Despite an estimated 90,000 new infections last year alone, national silence on the issue of HIV and AIDS prevails. A ‘national catastrophe’ is unfolding according to Pokrovsky, who leads the Federal AIDS Centre.
Francis Chimenya, citizen journalist from the Key Correspondents network
Two studies involving women in South Africa, Malawi, Uganda, Rwanda and Zimbabwe are exploring the use of a vaginal ring that delivers antiretroviral drugs, to see if it can prevent transmission of HIV.
The Ring Study is a clinical study by the International Partnership for Microbicides (IPM) and its sister study ASPIRE is being led by Microbicide Trial Network (MTN). Both studies began in June 2012 with about 4,580 women aged 18-45 in 22 sites across Africa.
A new way of administering antiretroviral treatment could revolutionise the current way people living with HIV take treatment. A new subdermal implant has been proven to be effective in the first 40 days, according to research published in the journal Antimicrobial Agents and Chemotherapy.
Individuals who choose not to disclose their HIV status are not more likely to suffer from depression or anxiety, have more problems with treatment adherence or worse HIV outcomes, according to a large study presented at the British HIV Association (BHIVA) conference in Brighton last week.